Skip to main content
Premium Trial:

Request an Annual Quote

AnaSpec, Geneva Bioinformatics

Premium
AnaSpec this week launched 15 new peptides for drug discovery research including Influenza Matrix Protein (62-70); MP (62-70); Cortistatin-29, human; and RSK3, Ribosomal S6 Kinase 3.
 

 
Geneva Bioinformatics has released a new version of its Phenyx protein identification software. Enhancements in Phenyx 2.5 include updated server-side code to accelerate searches; integration with the Institute for Systems Biology’s Trans Proteomics Pipeline and Proteome Software’s Scaffold; and improved web services that enable the integration of Phenyx into “any third-party proteomics pipeline.”
 
The company said it will be demonstrating the software at HUPO 2007 in Seoul, Korea, Oct. 6-10.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.